4.8 Article

Essential Role of BRCA2 in Ovarian Development and Function

Journal

NEW ENGLAND JOURNAL OF MEDICINE
Volume 379, Issue 11, Pages 1042-1049

Publisher

MASSACHUSETTS MEDICAL SOC
DOI: 10.1056/NEJMoa1800024

Keywords

-

Funding

  1. Breast Cancer Research Foundation
  2. National Institutes of Health [R35CA197458]
  3. Israel Science Foundation [1788/15, 1353/12]
  4. Israel Science Foundation
  5. NATIONAL CANCER INSTITUTE [R35CA197458] Funding Source: NIH RePORTER

Ask authors/readers for more resources

The causes of ovarian dysgenesis remain incompletely understood. Two sisters with XX ovarian dysgenesis carried compound heterozygous truncating mutations in the BRCA2 gene that led to reduced BRCA2 protein levels and an impaired response to DNA damage, which resulted in chromosomal breakage and the failure of RAD51 to be recruited to double-stranded DNA breaks. The sisters also had microcephaly, and one sister was in long-term remission from leukemia, which had been diagnosed when she was 5 years old. Drosophila mutants that were null for an orthologue of BRCA2 were sterile, and gonadal dysgenesis was present in both sexes. These results revealed a new role for BRCA2 and highlight the importance to ovarian development of genes that are critical for recombination during meiosis. (Funded by the Israel Science Foundation and others.)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available